TIAA CREF Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.29M Sell
2018
Q4
$925K Sell
2018
Q3
$1.28M Sell
2018
Q2
$2.49M Buy
2018
Q1
$426K Buy
2017
Q4
$343K Buy